Cargando…

Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis

OBJECTIVE: Currently, there are no data available on SARS-CoV-2 vaccine responses in pediatric-onset multiple sclerosis (POMS), and little is known about the course of SARS-CoV-2 infection in this age group. We therefore investigated humoral immune responses after COVID-19 vaccination and/or infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breu, Markus, Lechner, Christian, Schneider, Lisa, Tobudic, Selma, Winkler, Stefan, Siegert, Sandy, Baumann, Matthias, Seidl, Rainer, Berger, Thomas, Kornek, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Inc. 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979636/ https://www.ncbi.nlm.nih.gov/pubmed/36966598 http://dx.doi.org/10.1016/j.pediatrneurol.2023.02.017

Ejemplares similares

Epidemiology of Pediatric NMOSD in Germany and Austria
por: Lechner, Christian, et al.
Publicado: (2020)

SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
por: Schneider, Lisa, et al.
Publicado: (2022)

Renal Abscess: A Rare Complication of Paratyphoid Fever in an Immunocompetent Traveler from Southeast Asia
por: Schubert, Lorenz, et al.
Publicado: (2021)

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
por: Pokryszka, Jagoda, et al.
Publicado: (2022)

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
por: Tobudic, Selma, et al.
Publicado: (2022)

Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
por: Bruijstens, Arlette L, et al.
Publicado: (2022)

Human Borrelia miyamotoi Infection, Austria
por: Tobudic, Selma, et al.
Publicado: (2020)

Treatment and outcome of aquaporin-4 antibody–positive NMOSD: A multinational pediatric study
por: Paolilo, Renata Barbosa, et al.
Publicado: (2020)

Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families
por: Zrzavy, Tobias, et al.
Publicado: (2020)

Current Advances in Pediatric Onset Multiple Sclerosis
por: Fisher, Kristen S., et al.
Publicado: (2020)

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
por: Tobudic, Selma, et al.
Publicado: (2023)

Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies
por: Ali, Ahya, et al.
Publicado: (2021)

Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients
por: Tobudic, Selma, et al.
Publicado: (2012)

Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia
por: Bunyan, Reem, et al.
Publicado: (2021)

The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
por: Greene, Nupur, et al.
Publicado: (2022)

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
por: Schubert, Lorenz, et al.
Publicado: (2022)

Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study
por: Krajnc, Nik, et al.
Publicado: (2022)

B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients
por: Kornek, Barbara, et al.
Publicado: (2022)

Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
por: Capuano, Rocco, et al.
Publicado: (2021)

Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
por: Dominelli, Federica, et al.
Publicado: (2022)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis
por: Akbar, Nadine, et al.
Publicado: (2016)

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2020)

Long-term disability progression of pediatric-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2019)

The Outcome of COVID-19 in Pediatric-Onset Multiple Sclerosis Patients
por: Oncel, Ibrahim, et al.
Publicado: (2022)

An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
por: Kornek, Barbara
Publicado: (2015)

Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?
por: Tütüncü, Melih, et al.
Publicado: (2023)

Low nasal carriage of drug-resistant bacteria among medical students in Vienna
por: Gualdoni, Guido A., et al.
Publicado: (2012)

Association of miRNA and mRNA Levels of the Clinical Onset of Multiple Sclerosis Patients
por: Piotrzkowska, Danuta, et al.
Publicado: (2021)

Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
por: Ciampi, Ethel, et al.
Publicado: (2022)

MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis
por: Weygandt, Martin, et al.
Publicado: (2014)

Several household chemical exposures are associated with pediatric‐onset multiple sclerosis
por: Mar, Soe, et al.
Publicado: (2018)

Obesity in Pediatric-Onset Multiple Sclerosis: A French Cohort Study
por: Milles, Pauline, et al.
Publicado: (2021)

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
por: Margoni, Monica, et al.
Publicado: (2021)

Trends in the Epidemiology and Treatment of Pediatric-Onset Multiple Sclerosis in Alberta, Canada
por: Yearwood, Camille, et al.
Publicado: (2023)

Has the pandemic changed treatment strategy in multiple sclerosis?
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients
por: Thole, Linda Marie Laura, et al.
Publicado: (2023)

Humoral immune activation in amyotrophic lateral sclerosis patients
por: Rentzos, Michael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cr2adnkcj6imglc5egn059l0o3